Approvals/CIMA-AEMPS/TIOTEPA SEACROSS 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

TIOTEPA SEACROSS 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Seacross Pharma (Europe) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 5461d41260d17f9d
Drug Cima Aemps Name: TIOTEPA SEACROSS 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number: 90132
Holder Company Name: Seacross Pharma (Europe) Limited
Marketing Company Name: Pharmavic Iberica S.L.
Authorization Date: 2025-02-10
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 15 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Seacross Pharma (Europe) Limited

TIOTEPA

15 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 10, 2025

Approval ID

5461d41260d17f9d

Type

Standard